Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Rebecca V Steenaard"'
Autor:
Rebecca V. Steenaard, Marieke Rutjens, Madeleine H. T. Ettaieb, Max M. van Noesel, Harm R. Haak
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-10 (2022)
Abstract Adrenocortical carcinoma affects one in 5 million children each year. Since prognosis for children older than 4 years is limited, clinicians often choose aggressive treatment with etoposide, doxorubicin, cisplatin (EDP) and mitotane after re
Externí odkaz:
https://doaj.org/article/cd0f006417934f6088ce2c439333202b
Autor:
Rebecca V. Steenaard, Richard A. Feelders, Fadime Dogan, Peter M. van Koetsveld, Sara G. Creemers, Madeleine H. T. Ettaieb, Folkert J. van Kemenade, Harm R. Haak, Leo J. Hofland
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 2013 (2023)
The differentiation between benign and malignant adrenocortical tumors based on pathological assessment can be difficult. We present a series of 17 patients with unclear malignant tumors, of whom six had recurrent or metastatic disease. The assessmen
Externí odkaz:
https://doaj.org/article/8dd6353959154a04a0b15c6b72a9d90b
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 17:677-683
Introduction Mitotane is the only drug registered specifically for adrenocortical carcinoma. Finding the optimal dose for a patient is difficult due to large differences in bioavailability, toxicity and effect. We therefore look to improve personaliz
Autor:
Rebecca V. Steenaard, Thomas M. A. Kerkhofs, Myrte Zijlstra, Floortje Mols, Michiel N. Kerstens, Henry J. L. M. Timmers, Rachel S. van Leeuwaarde, Koen M. A. Dreijerink, Elisabeth M. W. Eekhoff, Els J. M. Nieveen van Dijkum, Eleonora P. M. Corssmit, Ellen Kapiteijn, Marjolein N. T. Kremers, Richard A. Feelders, Harm R. Haak
Publikováno v:
Cancers, 14, 6
Cancers, 14(6):1366. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(6):1366. MDPI AG
Cancers, 14
Steenaard, R V, Kerkhofs, T M A, Zijlstra, M, Mols, F, Kerstens, M N, Timmers, H J L M, van Leeuwaarde, R S, Dreijerink, K M A, Eekhoff, E M W, Nieveen van Dijkum, E J M, Corssmit, E P M, Kapiteijn, E, Kremers, M N T, Feelders, R A & Haak, H R 2022, ' Health-Related Quality of Life in Adrenocortical Carcinoma : Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry ', Cancers, vol. 14, no. 6, 1366 . https://doi.org/10.3390/cancers14061366
Cancers, 14(6):1366. MDPI Multidisciplinary Digital Publishing Institute
Cancers; Volume 14; Issue 6; Pages: 1366
Cancers, 14(6). MDPI
Cancers, 14(6):1366. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(6):1366. MDPI AG
Cancers, 14
Steenaard, R V, Kerkhofs, T M A, Zijlstra, M, Mols, F, Kerstens, M N, Timmers, H J L M, van Leeuwaarde, R S, Dreijerink, K M A, Eekhoff, E M W, Nieveen van Dijkum, E J M, Corssmit, E P M, Kapiteijn, E, Kremers, M N T, Feelders, R A & Haak, H R 2022, ' Health-Related Quality of Life in Adrenocortical Carcinoma : Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry ', Cancers, vol. 14, no. 6, 1366 . https://doi.org/10.3390/cancers14061366
Cancers, 14(6):1366. MDPI Multidisciplinary Digital Publishing Institute
Cancers; Volume 14; Issue 6; Pages: 1366
Cancers, 14(6). MDPI
Simple Summary: Patients with the rare cancer adrenocortical carcinoma are exposed to many symptoms and treatment side-effects. Research on how this can affect their health-related quality of life (HRQoL) is limited, however. This article includes th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dedd2c6e746e1092966091bf369ec74c
Autor:
Marieke Rutjens, Rebecca V Steenaard, Madeleine H.T. Ettaieb, Noesel Max M. van, Harm R. Haak
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Journal of the Endocrine Society
Journal of the endocrine society, 4(5):040. Oxford University Press
Journal of the endocrine society, 4(5):040. Oxford University Press
Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC. In 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60fa2d8f07b236d91256535613320a0f
https://doi.org/10.1210/jendso/bvaa040
https://doi.org/10.1210/jendso/bvaa040
Autor:
Madoka Sunamura, H. Boersma, Marcel L. Geleijnse, Rebecca V. Steenaard, R.T. van Domburg, H. J. G. van den Berg-Emons, N. ter Hoeve
Publikováno v:
Netherlands Heart Journal, 25(11), 618-628. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal
Background Hospital length of stay after acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention (pPCI) has reduced, resulting in more limited patient education during admission. Therefore, systematic participation i
Publikováno v:
Cancers, Vol 11, Iss 10, p 1500 (2019)
Cancers
Cancers
Insight into the health-related quality of life (HRQoL) impact of adrenocortical carcinoma (ACC) is important. The disease and its treatment options potentially have an impact on HRQoL. For patients with limited survival, HRQoL research is of utmost
Publikováno v:
Journal of the Endocrine Society
Background: Adrenocortical carcinoma (ACC) is a rare disease with often poor prognosis. Previous research has shown that surgery in a Dutch Adrenal Network (DAN) center increases the chance of survival. We aim to explore the determinants and survival
Autor:
Abbas Dehghan, Marjolein J. Peters, Oscar H. Franco, Albert Hofman, Lisette Stolk, Symen Ligthart, André G. Uitterlinden, Rebecca V. Steenaard, Joyce B. J. van Meurs
Publikováno v:
Clinical Epigenetics, 7. BioMed Central Ltd.
Clinical Epigenetics
Clinical Epigenetics
Background Tobacco smoking, a risk factor for coronary artery disease (CAD), is known to modify DNA methylation. We hypothesized that tobacco smoking modifies methylation of the genes identified for CAD by genome-wide association study (GWAS). Result